Atara Biotherap
(ATRA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,771 | -228,302 | -153,730 | -69,639 | -88,105 |
| Depreciation Amortization | 863 | 6,677 | 5,372 | 3,840 | 2,089 |
| Accounts receivable | 39,824 | -39,235 | 737 | 349 | 318 |
| Accounts payable and accrued liabilities | -1,886 | -9,211 | -4,760 | -3,384 | -4,588 |
| Other Working Capital | 19,552 | -61,468 | -63,603 | -64,310 | -13,482 |
| Other Operating Activity | -22,011 | 61,109 | 2,434 | -15,349 | 19,239 |
| Operating Cash Flow | $-38,429 | $-270,430 | $-213,550 | $-148,493 | $-84,529 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -5,608 | 112,384 | 61,129 | 1,300 | 62,820 |
| PPE Investments | -399 | -4,193 | -4,156 | -4,024 | -2,605 |
| Other Investing Activity | 0 | 94,765 | 94,765 | 94,765 | 0 |
| Investing Cash Flow | $-6,007 | $202,956 | $151,738 | $92,041 | $60,215 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 30,605 | N/A | N/A | N/A |
| Debt Repayment | -312 | -518 | -396 | -190 | -64 |
| Common Stock Issued | 640 | 23,812 | 21,968 | 21,921 | 20,635 |
| Other Financing Activity | -93 | -815 | -778 | -723 | -720 |
| Financing Cash Flow | $235 | $53,084 | $20,794 | $21,008 | $19,851 |
| Beginning Cash Position | 93,088 | 107,478 | 107,478 | 107,478 | 107,478 |
| End Cash Position | 48,887 | 93,088 | 66,460 | 72,034 | 103,015 |
| Net Cash Flow | $-44,201 | $-14,390 | $-41,018 | $-35,444 | $-4,463 |
| Free Cash Flow | |||||
| Operating Cash Flow | -38,429 | -270,430 | -213,550 | -148,493 | -84,529 |
| Capital Expenditure | -399 | -4,193 | -4,156 | -4,024 | -2,605 |
| Free Cash Flow | -38,828 | -274,623 | -217,706 | -152,517 | -87,134 |